E. Lin
Impact in
- Gastroenterology top 2%
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 17
- Colorectal Cancer Treatments and Studies 11
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Surgical Treatments 3
-
- Epigenetics and DNA Methylation 3
- Co-authors
- Scott Kopetz (5 shared papers)Lanlan Shen (3 shared papers)Saira Ahmed (3 shared papers)Jean‐Pierre J. Issa (3 shared papers)Yi Guo (2 shared papers)Yutaka Kondo (2 shared papers)Tzyy‐Wen Chiou (2 shared papers)Horng‐Jyh Harn (2 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Cancer (2 papers)Clinical Cancer Research (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Blood (1 paper)
- Partner nations
- United StatesTaiwanGermany
In The Last Decade
E. Lin
34 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 104
- Gastroenterology 185
- Oncology 811
- Hepatology 221
- Cancer Research 400
- Hematology 235
Countries citing papers authored by E. Lin
This map shows the geographic impact of E. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Lin more than expected).
Fields of papers citing papers by E. Lin
This network shows the impact of papers produced by E. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Lin. The network helps show where E. Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 429 | |
| 2 | 2009 | 261 | |
| 3 | 2019 | 193 | |
| 4 | 2009 | 175 | |
| 5 | 2008 | 128 | |
| 6 | 2013 | 99 | |
| 7 | 2006 | 92 | |
| 8 | 2010 | 92 | |
| 9 | 2014 | 69 | |
| 10 | 2006 | 69 | |
| 11 | 2010 | 56 | |
| 12 | Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis. | 2011 | 51 |
| 13 | 2008 | 47 | |
| 14 | 2007 | 41 | |
| 15 | 2010 | 37 | |
| 16 | 2011 | 29 | |
| 17 | 2011 | 28 | |
| 18 | 2006 | 28 | |
| 19 | 1992 | 23 | |
| 20 | 2011 | 21 |
About E. Lin
E. Lin is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 35 papers that have together received 2.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Cancer Treatment and Pharmacology (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Lung Cancer Treatments and Mutations (4 papers), Acute Myeloid Leukemia Research (3 papers), Epigenetics and DNA Methylation (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). The work is most often cited by research in Gastroenterology (185 citations), Oncology (811 citations), Hepatology (221 citations), Cancer Research (400 citations) and Hematology (235 citations). E. Lin has collaborated with scholars based in United States, Taiwan and Germany. Frequent co-authors include Scott Kopetz, Lanlan Shen, Saira Ahmed, Jean‐Pierre J. Issa, Yi Guo, Yutaka Kondo, Tzyy‐Wen Chiou, Horng‐Jyh Harn, Yu-Shuan Chen and James L. Abbruzzese. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.